Haematologica (Aug 2020)
LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA
- Audrey Belot,
- Ophélie Gourbeyre,
- Alexis Fay,
- Anais Palin,
- Céline Besson-Fournier,
- Chloé Latour,
- Corey R. Hopkins,
- George F. Tidmarsh,
- Hélène Coppin,
- Marie-Paule Roth,
- Matthew R. Ritter,
- Charles C. Hong,
- Delphine Meynard
Affiliations
- Audrey Belot
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Ophélie Gourbeyre
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Alexis Fay
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Anais Palin
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Céline Besson-Fournier
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Chloé Latour
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Corey R. Hopkins
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, USA
- George F. Tidmarsh
- La Jolla Pharmaceutical Company, San Diego, CA, USA
- Hélène Coppin
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Marie-Paule Roth
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- Matthew R. Ritter
- La Jolla Pharmaceutical Company, San Diego, CA, USA
- Charles C. Hong
- Division of Cardiovascular Medicine, University of Maryland School of Medicine, Baltimore, USA
- Delphine Meynard
- IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, Toulouse, France
- DOI
- https://doi.org/10.3324/haematol.2019.236133
- Journal volume & issue
-
Vol. 105,
no. 8
Abstract
No abstracts available.
